首页> BMC neurology> Cholinesterase inhibitor to prevent falls in Parkinson's disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson's disease.

Cholinesterase inhibitor to prevent falls in Parkinson's disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson's disease.

导出 OA

翻译打印收藏纠错

第一作者： S,Neumann

第一单位： University of Bristol, Population Health Sciences, Bristol Medical School, Faculty of Health Sciences, Bristol, UK.

作者： S,Neumann ^[1] ; J,Taylor ^[1] ; A,Bamford ^[1] ; C,Metcalfe ^[1] ; D M,Gaunt ^[1] ; A,Whone ^[2] ; D,Steeds ^[1] ; S R,Emmett ^[3] ; W,Hollingworth ^[1] ; Y,Ben-Shlomo ^[1] ; E J,Henderson ^[4]

作者单位： University of Bristol, Population Health Sciences, Bristol Medical School, Faculty of Health Sciences, Bristol, UK. ^[1] University of Bristol, Population Health Sciences, Bristol Medical School, Faculty of Health Sciences, Bristol, UK.;North Bristol NHS Trust, Bristol, UK. ^[2] University of Bristol, Population Health Sciences, Bristol Medical School, Faculty of Health Sciences, Bristol, UK.;Royal United Hospitals Bath NHS Foundation Trust, Bath, UK. ^[3] University of Bristol, Population Health Sciences, Bristol Medical School, Faculty of Health Sciences, Bristol, UK. Emily.Henderson@bristol.ac.uk.;Royal United Hospitals Bath NHS Foundation Trust, Bath, UK. Emily.Henderson@bristol.ac.uk. ^[4]

关键词 Accidental falls Cholinesterase inhibitor Parkinson disease Randomized controlled trials Rivastigmine

医学主题词胆碱酯酶抑制剂(Cholinesterase Inhibitors);双盲法(Double-Blind Method);步态障碍, 神经性(Gait Disorders, Neurologic);人类(Humans);帕金森病(Parkinson Disease);生活质量(Quality of Life)

DOI 10.1186/s12883-021-02430-2

PMID 34715821

发布时间 2024-04-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交